| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |